ISOGENICA RENEWS RESEARCH COLLABORATION WITH ASTRAZENECA

Isogenica Ltd reported that it has entered into a new research collaboration with AstraZeneca. The research programme centres on the use of Isogenica's CIS display technology for the discovery of peptides which are specific for, and biologically active against, targets provided by AstraZeneca. The collaboration builds upon a successful pilot study that was initiated by the parties in 2004, a release stated.

Pharmabiz (http://pharmabiz.com/article/detnews.asp?articleid=34260§ionid=)